U.S. Markets closed

Madrigal Pharma Is Exploring Sale After Receiving Takeover Interest

Manuel Baigorri, Cristin Flanagan
Madrigal Pharma Is Exploring Sale After Receiving Takeover Interest

Madrigal Pharmaceuticals Inc., with just nine employees and a market value of about $4.3 billion, is exploring a sale after receiving takeover interest from other drugmakers eyeing treatments for a liver disease linked to obesity, people familiar with the matter said. The deliberations are at an early stage and Madrigal may opt to continue operations on its own, they said. Representatives for Madrigal declined to comment, while Centerview didn’t immediately respond to calls.